General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. At a Glance
Jayant Agro shipped ₹2,406 Cr in sales and ₹50.4 Cr in net profit for FY26, holding the line on a commodity business that keeps the margin squeeze on. Quarterly momentum peaked in Q3 (₹672 Cr sales, ₹16.2 Cr net profit) before rolling back in Q4. The P/E sits at 13.3x—cheaper than peers at 28.9x—but that gap mirrors the company’s tighter operating margin of 4.3% against a 12.6% peer median, a structural difference rooted in the 59% castor oil revenue weight.
Management continues to reappoint its executive directors for five-year terms. Net cash sat at ₹119 Cr (cash of ₹12.5 Cr minus debt of ₹131 Cr would equal -₹118.5 Cr net debt, not net cash—so the company is net indebted). Capex on derivatives capacity rolls on.
What keeps the market watching? A ₹25.4 Cr acquisition of VCPL in May 2026 turned the company into a bigger polyols player, but the multiple still refuses to budge.
2. Introduction
Jayant Agro-Organics is the castor industry’s second-generation leader. Born in 1992 in Mumbai, the Udeshi family has spent 50+ years in castor seeds, oil, and now derivatives. The company operates four manufacturing sites across India and exports to 70+ countries, with 83% of FY26 sales leaving the country.
In the 12 months to March 2026, two governance moves reset the stage: the merger of Jayant Finvest into JAOL (completed December 2024) and the May 2026 acquisition of Vithal Castor Polyols Private Limited (VCPL) for ₹25.4 Cr from JV partner Mitsui Chemicals. VCPL manufacture polyols—a higher-margin derivative. The goal: shift the product mix away from commodity castor oil and into specialty derivatives with margins that don’t depend on global castor prices.
The board approved a 70% dividend (₹3.50 per share) on May 29, 2026. The company’s rating from ICRA stands at A- (Stable).
3. Business Model: WTF Do They Even Do?
The Jayant Group is oleochemicals—castor-based, mostly.
The split: Castor oil (the commodity raw material) accounts for ~59% of FY23 revenue. Derivatives—hydrogenated castor oil (HCO), dehydrated castor oil (Decasoil), sebacic acid, polyols, organic fertiliser (Pragati), pharma-grade castor oil—make up ~41%. The company has 90 SKUs in the portfolio, with 20–25 driving real volumes.
End markets are wild. Agriculture, aerospace, cosmetics, electronics, lubricants, pharmaceuticals, plastics, rubber, textiles—JAOL ships into all of it. That diversification sounds protective until you realize castor prices move on India’s crop output and US tariffs, so when farmers are struggling or supply tightens, everyone bleeds.
The export game: 83% of FY26 sales went abroad, 20% to the US alone. The US depends on India for 85–90% of castor oil imports and castor derivatives, so JAOL has a structural moat there. But the US 50% tariff on Indian products (rolled out 2025) creates pricing friction and volume risk.
The capex trap: The company is mid-way through a ₹100 Cr four-year capex to add higher-margin derivatives. ₹15 Cr went into FY25, more is slated. The story is that derivatives will one day move the needle on margins. The reality is that until they do, JAOL remains a glorified raw-material play where ₹2,406 Cr in sales spits out 2.1% net margin.
4. Financials Overview
Figures are consolidated, in ₹ crore.
Metric
FY26
FY25
YoY Change
Revenue
2,406
2,528
-4.8%
EBITDA
126.7
128.4
-1.3%
Net Profit
50.4
54.9
-8.2%
EPS
16.8
18.3
-8.2%
Quarterly trajectory: Sales bounced from ₹587 Cr in Q3 to ₹647 Cr in Q4—a 10% jump. Net profit shot from ₹9.7 Cr in Q3 to ₹17.7 Cr in Q4 (Q3 ×4 = ₹38.8 Cr annualised). The operating margin held steady at 5.2% in Q4 vs. 4.5% in Q3. So full-year slump masked a strong quarter-end bounce. Was it order pull-forward before the US tariff implementation, or genuine improvement? The concalls will tell, but the market has no visibility.
Interest cost climbed to ₹15.4 Cr in FY26 from ₹18.9 Cr in FY25—a drop. Working capital debt improved. The tax rate stayed at ~27%, so a ₹71 Cr PBT fell to ₹50.4 Cr net.
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how
